Coenzyme Q(10) and statin myalgia: what is the evidence?

Abstract

Statins lower cholesterol by inhibiting 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme in the biosynthesis of cholesterol. However, severe adverse events, including myalgias and rhabdomyolysis, have been reported with statin treatment. Different mechanisms have been proposed to explain statin-induced myopathy, including… (More)
DOI: 10.1007/s11883-010-0134-3

Topics

  • Presentations referencing similar topics